CD79A and COVID-19: Our results revealed that, even though children presented a generally naïve, non-activated, immune profile, they had efficiently generated SARS-CoV-2 specific antibody responses, in levels that did not differ from the ones in AMD (p < 0.103 for IgA; p > 0.999 for IgG) or ASD (p < 0.916 for IgA; p > 0.999 for IgG) COVID-19 patients.